Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Hani M Babiker"'
Autor:
Michael S. Rutenberg, MD, PhD, Bradford S. Hoppe, MD, MPH, Jason S. Starr, DO, Ziad Awad, MD, Mathew Thomas, MBBS, MD, Christopher G. Morris, MS, Perry Johnson, PhD, Randal H. Henderson, MD, MBA, Jeremy C. Jones, MD, Bharatsinh Gharia, MBBS, MD, Steven Bowers, MD, Herbert C. Wolfsen, MD, Sunil Krishnan, MBBS, MD, Stephen J. Ko, MD, Hani M. Babiker, MD, Romaine C. Nichols, Jr, MD
Publikováno v:
International Journal of Particle Therapy, Pp 18-29 (2022)
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the hear
Externí odkaz:
https://doaj.org/article/6e0ce34c85cc410c8a3e146ab69d68ad
Autor:
Ritika Halder, Eric Brucks, Ce Cheng, Kathylynn Saboda, Hani M. Babiker, Ali Mcbride, Alejandro Recio-Boiles
Publikováno v:
Thrombosis Update, Vol 9, Iss , Pp 100121- (2022)
Externí odkaz:
https://doaj.org/article/40dc5763f3974cf0a881beee189f836e
Autor:
Umang Swami, Raquel Mae Zimmerman, Roberto H. Nussenzveig, Edgar Javier Hernandez, Yeonjung Jo, Nicolas Sayegh, Sergiusz Wesolowski, Lesli A. Kiedrowski, Pedro C. Barata, Gordon Howard Lemmon, Mehmet A. Bilen, Elisabeth I. Heath, Lakshminarayan Nandagopal, Hani M. Babiker, Sumanta K. Pal, Michael Lilly, Benjamin L. Maughan, Benjamin Haaland, Mark Yandell, Oliver Sartor, Neeraj Agarwal
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BRCA1-mutated prostate cancer has been shown to be less responsive to poly (ADP-ribose) polymerase (PARP) inhibitors as compared to BRCA2-mutated prostate cancer. The reason for this differential response is not clear. We hypothesized this differenti
Externí odkaz:
https://doaj.org/article/4e03b0f2c01f46158e4c977641bd2a04
Publikováno v:
Expert Opinion on Investigational Drugs. :1-13
Publikováno v:
Expert Opinion on Investigational Drugs. 32:69-75
Publikováno v:
Case Reports in Hematology, Vol 2019 (2019)
Thrombotic thrombocytopenia purpura (TTP) is a hematological emergency that requires rapid assessment followed by prompt initiation of therapy due to high mortality associated with delayed treatment. TTP has many causes including heritable syndromes,
Externí odkaz:
https://doaj.org/article/26ee61ae4c274a008b7c7b2d3e0607aa
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
The low prevalence rate and limited literature on eccrine carcinoma (EC) pose a challenge to properly diagnosing and treating this rare malignancy. EC lesions tend to present similarly to other cutaneous neoplasms and dermatitis-like conditions. Effi
Externí odkaz:
https://doaj.org/article/c530d867e848408d83c1151aa10b5444
Autor:
Gregory J. Gores, Hani M. Babiker, Alexander T. Baker, Daniel H. Ahn, George Vasmatzis, Benjamin R. Kipp, Rish K. Pai, Bertram L. Jacobs, James M Bogenberger, Nathalie Meurice, Rory L. Smoot, Oumar Barro, Marcela Salomao, Mansi Arora, Chelsae Dumbauld, Bolni Marius Nagalo, Michael T. Barrett, Mitesh J. Borad, Natalie Elliott, Heidi E. Kosiorek, Tanios Bekaii-Saab, Thomas DeLeon, Faaiq N Aslam, Yumei Zhou, Pedro Luiz Serrano Uson Junior, Mohammad Bassam Sonbol, Kenneth H. Buetow, Joachim L. Petit, Jun Yin, Aaron S. Mansfield, Amit Mahipal
Publikováno v:
Digestive Diseases and Sciences. 67:3797-3805
FGFR2 genomic alterations are observed in 10–20% of cholangiocarcinoma (CCA). Although FGFR2 fusions are an important actionable target, FGFR2 protein expression has not been thoroughly characterized. To evaluate FGFR2 protein expression in cholang
Autor:
Alejandro Recio Boiles, Ali McBride, Daniel O. Persky, Emad Elquza, Andrew S. Kraft, Cindy Banh, Alicia Ortega, Alejandra Arredondo, Kassie Notbohm, Hani M. Babiker, Kendall Valsvik
Publikováno v:
Supportive Care in Cancer
Purpose To characterize and compare both the outcome and cost of treatment of outpatient (OP) and inpatient (IP) ifosfamide therapy. Methods A single-center retrospective chart review of patients 18 years and older receiving ifosfamide therapy. The p